(Q34703673)

English

Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

Stanley J Szefler

10

object named as

Stanley J Szefler

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert F Lemanske

7

object named as

Robert F Lemanske

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert S. Zeiger

4

object named as

Robert S Zeiger

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert C Strunk

9

object named as

Robert C Strunk

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

object named as

David T Mauger

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Christine A Sorkness

6

object named as

Christine A Sorkness

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

5

object named as

Ian M Paul

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute

12

object named as

Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Lynn M. Taussig

11

object named as

Lynn M Taussig

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Li Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Christopher S Hollenbeak

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Fernando D Martinez

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

127

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

161-6, 166.e1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

7 July 2018

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

7 July 2018

Single-inhaler combination therapy for asthma: a review of cost effectiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

7 July 2018

Cost effectiveness of guideline advice for children with asthma: a literature review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

7 July 2018

Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

7 July 2018

Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost-effectiveness of asthma control: an economic appraisal of the GOAL study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Country-specific cost-effectiveness of early intervention with budesonide in mild asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061816

26 October 2018

The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of pediatric asthma treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary health statistics for U.S. children: National Health Interview Survey, 1998.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of current and optimal treatment for adult asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the cost of illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/21211651

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JACI.2010.10.035

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34703673&oldid=2015139215"